Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies

Immunotherapy, especially PD-1/PD-L1 checkpoint blockade immunotherapy, has led tumor therapy into a new era. However, the vast majority of patients do not benefit from immunotherapy. One possible reason for this lack of response is that the association between tumors, immune cells and metabolic rep...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Ma, Guofeng, Li, Chun, Zhang, Zhilei, Liang, Ye, Liang, Zhijuan, Chen, Yuanbin, Wang, Liping, Li, Dan, Zeng, Manqin, Shan, Wenhong, Niu, Haitao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314994/
https://ncbi.nlm.nih.gov/pubmed/34327138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.697894
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak